Piper Sandler Downgrades Design Therapeutics Inc (DSGN) to Neutral
Tweet Send to a Friend
Piper Sandler analyst Yasmeen Rahimi downgraded Design Therapeutics Inc (NASDAQ: DSGN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
